The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Åke Borg

Åke Borg

Principal investigator

Åke Borg

The mutational landscape of the SCAN‐B real‐world primary breast cancer transcriptome

Author

  • Christian Brueffer
  • Sergii Gladchuk
  • Christof Winter
  • Johan Vallon-Christersson
  • Cecilia Hegardt
  • Jari Häkkinen
  • Anthony George
  • Yilun Chen
  • Anna Ehinger
  • Christer Larsson
  • Niklas Loman
  • Martin Malmberg
  • Lisa Ryden
  • Åke Borg
  • Lao Saal
Show all

Summary, in English

Breast cancer is a disease of genomic alterations, of which the panorama of somatic mutations and how these relate to subtypes and therapy response is incompletely understood. Within SCAN‐B (ClinicalTrials.gov: NCT02306096), a prospective study elucidating the transcriptomic profiles for thousands of breast cancers, we developed a RNA‐seq pipeline for detection of SNVs/indels and profiled a real‐world cohort of 3,217 breast tumors. We describe the mutational landscape of primary breast cancer viewed through the transcriptome of a large population‐based cohort and relate it to patient survival. We demonstrate that RNA‐seq can be used to call mutations in genes such as PIK3CA, TP53, and ERBB2, as well as the status of molecular pathways and mutational burden, and identify potentially druggable mutations in 86.8% of tumors. To make this rich dataset available for the research community, we developed an open source web application, the SCAN‐B MutationExplorer (http://oncogenomics.bmc.lu.se/MutationExplorer). These results add another dimension to the use of RNA‐seq as a clinical tool, where both gene expression‐ and mutation‐based biomarkers can be interrogated in real‐time within 1 week of tumor sampling.

Department/s

  • Translational Oncogenomics
  • LUCC: Lund University Cancer Centre
  • Transl oncogenomics
  • Breastcancer-genetics
  • Pathology, Lund
  • Tumor Cell Biology
  • Faculty office - The medical degree programme board
  • Division of Translational Cancer Research
  • Breast/ovarian cancer
  • Breast cancer treatment
  • The Liquid Biopsy and Tumor Progression in Breast Cancer
  • Breast Cancer Surgery
  • Surgery (Lund)
  • Familial Breast Cancer

Publishing year

2020-09-14

Language

English

Publication/Series

EMBO Molecular Medicine

Volume

12

Issue

10

Document type

Journal article

Publisher

Wiley-Blackwell

Topic

  • Cancer and Oncology
  • Bioinformatics and Systems Biology
  • Bioinformatics (Computational Biology)

Keywords

  • cancer
  • breast cancer
  • mutation
  • RNA-seq
  • survival
  • transcriptome

Status

Published

Project

  • Sweden Cancerome Analysis Network - Breast (SCAN-B): a large-scale multicenter infrastructure towards implementation of breast cancer genomic analyses in the clinical routine
  • RNA sequencing for molecular diagnostics in breast cancer

Research group

  • Translational Oncogenomics
  • Tumor Cell Biology
  • The Liquid Biopsy and Tumor Progression in Breast Cancer
  • Breast Cancer Surgery
  • Familial Breast Cancer

ISBN/ISSN/Other

  • ISSN: 1757-4684